Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 11,332,482 | 05/17/2022 | 2017-114 |
The biological properties of trifluoromethyl compounds (e.g,
CF3) have led to their ubiquity in pharmaceuticals, yet their chemical
properties have made their preparation a substantial challenge, necessitating
innovative chemical solutions. For
example, strong, non-interacting C-F bonds lend metabolic stability while
simultaneously limiting the ability of chemical transformations to forge the
relevant linkages and install the CF3 unit. When these same synthetic considerations are
extended toward the synthesis of trifluoromethylated positron emission
tomography (PET) tracers, the situation becomes more complex.
UC Berkeley researchers discovered an unusual alternative
mechanism, in which borane abstracts fluoride from the CF3 group in a gold
complex. The activated CF2 fragment can then bond to a wide variety of
other carbon substituents added to the same gold center. Return of the fluoride
liberates a trifluoromethylated compound from the metal. This mechanism would
be useful for the introduction of radioactive fluoride substituents for
potential tracers to be used for positron emission tomography applications.
PET, positron emission tomography, radioactive, tracer, trifluoromethyl